Kaplan-Meier analysis of OS revealed that patients with tumours displaying high nuclear or cytoplasmic RBM3 expression who received oxaliplatin based treatment as first-line chemotherapy had significantly longer survival compared to all other strata (Fig 3C and 3D). The gene discussed is RBM3; the disease is neoplasm.